Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response - Loibl, Sibylle; Schneeweiss, Andreas; Huober, J.; Braun, M.; Rey, J.; Blohmer, J. -U.; Furlanetto, J.; Zahm, D. -M.; Hanusch, C.; Thomalla, J.; Jackisch, C.; Staib, P.; et al. (Annals of oncology, 2022)
Gesehen am 19.01.2023